Automated Antimicrobial Susceptibility Testing Market - Competitive Landscape: bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation

Increasing multidrug resistance research, new product launches, and rising number of development programs and funding among others are major factors that are expected to drive growth of the automated antimicrobial susceptibility testing market.

Contract research organizations perform various research and development activities involving AST and multidrug resistivity testing. Increasing research and development of small molecules by various manufacturing organizations is expected to increase the adoption of AST during the forecast period. For instance, according to Cambrex Corporation’s report 2017 on small molecules, small molecules are expected to gain major traction in the pharmaceutical industry, with the approval of 34 new small molecule entities by the U.S. Food and Drug Administration (FDA) in 2017.

Get PDF Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2622

Key players are engaged in launching susceptibility testing systems in the market, in order to expand its product portfolio. For instance, in March 2016, Thermo Fisher Scientific launched antimicrobial susceptibility testing for Tedizolid, enabling microbiology laboratories to perform Tedizolid susceptibility testing of fastidious and non-fastidious Gram positive organisms, which cause acute bacterial skin and skin structure infections (ABSSSIs) in adults. Increasing launch of such AST testing could result in increasing adoption of susceptibility plates during the forecast period.

Moreover, in 2017, bioMérieux launched ETEST Ceftolozane/Tazobactam and ETEST Ceftazidime/Avibactam, which determines the minimum inhibitory concentration (MIC) values necessary to effectively treat infections caused by multidrug resistant organisms.

Rising funding for research of antibiotic resistant microbes is expected to boost the automated antimicrobial susceptibility testing market revenue over the forecast period. For instance, in November 2017, Symcel AB, a company engaged in cell-based assay tool for real-time cell metabolism measurements, secured US$ 4.23 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.

Request for Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2622

Key players operating in the global automated antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.